ICU Medical Inc. Executive Compensation Details Revealed
Ticker: ICUI · Form: DEF 14A · Filed: Apr 3, 2025 · CIK: 883984
| Field | Detail |
|---|---|
| Company | Icu Medical Inc/De (ICUI) |
| Form Type | DEF 14A |
| Filed Date | Apr 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, equity-awards, def-14a
TL;DR
ICU Medical's 2024 exec comp filing shows $10.9M in new equity awards for PEOs, plus unvested prior year awards.
AI Summary
ICU Medical Inc. filed its DEF 14A on April 3, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to both PEO (Principal Executive Officer) and Non-PEO NEOs (Named Executive Officers), with specific values for reported, unvested, vested, and forfeited awards. For instance, PEOs received equity awards with a reported value of $10,939,000 during 2024, and $1,668,000 in equity awards granted in prior years remained unvested.
Why It Matters
This filing provides transparency into how ICU Medical Inc. compensates its top executives, which can influence investor decisions and perceptions of the company's governance and financial strategy.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but details on executive compensation can sometimes signal potential governance issues or significant changes in pay philosophy.
Key Numbers
- $10,939,000 — PEO Equity Awards Granted (2024) (Reported value of equity awards granted to the Principal Executive Officer during the 2024 fiscal year.)
- $1,668,000 — PEO Unvested Prior Year Equity Awards (2024) (Value of equity awards granted to the Principal Executive Officer in prior years that remained unvested as of the end of the 2024 fiscal year.)
- $1,038,000 — PEO Vested Prior Year Equity Awards (2024) (Value of equity awards granted to the Principal Executive Officer in prior years that vested during the 2024 fiscal year.)
- $1,038,000 — PEO Vested Equity Awards (2024) (Value of equity awards granted to the Principal Executive Officer during the 2024 fiscal year that vested.)
Key Players & Entities
- ICU MEDICAL INC/DE (company) — Filer of the DEF 14A
- 951 CALLE AMANECER (address) — Business and Mail Address
- SAN CLEMENTE, CA 92763-6212 (address) — City, State, and ZIP Code
- 949-366-2183 (phone_number) — Business Phone Number
FAQ
What was the total reported value of equity awards granted to the Principal Executive Officer (PEO) in 2024?
The total reported value of equity awards granted to the PEO during the 2024 fiscal year was $10,939,000.
How much in equity awards granted in prior years remained unvested for PEOs at the end of 2024?
As of the end of the 2024 fiscal year, $1,668,000 in equity awards granted in prior years remained unvested for PEOs.
What was the value of equity awards granted to Non-PEO NEOs during 2024?
The filing indicates that for Non-PEO NEOs, equity awards granted during the year had a reported value of $1,038,000.
Did any equity awards granted to PEOs fail to meet vesting conditions in 2024?
Yes, equity awards granted to PEOs that failed to meet vesting conditions during the 2024 fiscal year had a reported value of $1,038,000.
What is the fiscal year end for ICU Medical Inc. as reported in this filing?
The fiscal year end for ICU Medical Inc. is December 31 (1231).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 3, 2025 regarding ICU MEDICAL INC/DE (ICUI).